Harmony Biosciences Holdings, Inc. today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately $239M in Q3 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback